Increasing Prevalence and Risk Factors for Multifocal Osteonecrosis in Patients Who Have Corticosteroid-Associated Osteonecrosis of the Femoral Head: A 15-Year Multicenter Study
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2025.05.043 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Keiji Otaka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya City, Aichi, Japan. Hauptthemen laut MEDLINE: Femur Head Necrosis, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Hiroshima University, Kanazawa University, Shinshu University.
Abstract (Originalsprache)
BACKGROUND: Multifocal osteonecrosis (MFON) is a rare condition affecting multiple bone sites, with limited epidemiological data available. This study investigated the frequency, trends, and risk factors for MFON in patients aged > 15 years who had corticosteroid-associated osteonecrosis of the femoral head (ONFH) using data from a multicenter sentinel monitoring system in Japan. METHODS: Data from 658 patients between 2009 and 2023 were analyzed. The MFON was defined as osteonecrosis involving three or more separate anatomical sites. The frequency and trends of MFON were assessed across three 5-year periods. The risk factors for MFON were analyzed using data from 2014 onward, when smoking history data became available. The group with no necrosis other than that in the femoral head was defined as the non-MFON group, and the demographics and comorbidities were compared between the MFON and non-MFON groups. The risk factors were analyzed using univariate and logistic regression analyses. RESULTS: The frequency of MFON was 5.3% during the entire period and increased significantly over time (1.6, 7.4, and 8.0%; P < 0.01). The knee joint was the most common site of osteonecrosis, and all patients had knee joint involvement. The MFON group was younger (P < 0.001) and had more women (P < 0.05) than the non-MFON group and had significantly more patients who had systemic lupus erythematosus (SLE) and hematological tumors (both P < 0.01). The independent risk factors for MFON included age < 40 years (P < 0.05), SLE (P < 0.05), and hematological tumors (P < 0.001). CONCLUSIONS: The frequency of MFON in patients who had corticosteroid-associated osteonecrosis of the femoral head was 5.3%. Young patients, those who have SLE, or those who have hematological tumors are at a higher risk of MFON and should be considered for MFON screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya City, Aichi, Japan.
- Department of Orthopaedic Surgery, Yamaguchi University Graduate School of Medicine, Ube City, Yamaguchi, Japan.
- Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka City, Osaka, Japan.
- Department of Orthopaedic Surgery, Kansai Rosai Hospital, Amagasaki City, Hyogo, Japan; Department of Orthopaedic Medical Engineering, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
- Department of Orthopaedic Medical Engineering, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
Förderung
- Hiroshima University
- Kanazawa University
- Shinshu University
- Kyushu University
- University of the Ryukyus
- University of Miyazaki
- Sapporo Medical University
- Yamagata University
Zitieren
APA
Otaka, K., Sakai, T., Fukushima, W., Takegami, Y., Ando, W., Imagama, S., & Sugano, N. (2025). Increasing Prevalence and Risk Factors for Multifocal Osteonecrosis in Patients Who Have Corticosteroid-Associated Osteonecrosis of the Femoral Head: A 15-Year Multicenter Study. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2025.05.043
Vancouver
Otaka K, Sakai T, Fukushima W, Takegami Y, Ando W, Imagama S, et al. Increasing Prevalence and Risk Factors for Multifocal Osteonecrosis in Patients Who Have Corticosteroid-Associated Osteonecrosis of the Femoral Head: A 15-Year Multicenter Study. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2025.05.043
BibTeX
@article{Otaka2025,
author = {Otaka, Keiji and Sakai, Takashi and Fukushima, Wakaba and Takegami, Yasuhiko and Ando, Wataru and Imagama, Shiro and Sugano, Nobuhiko},
title = {Increasing Prevalence and Risk Factors for Multifocal Osteonecrosis in Patients Who Have Corticosteroid-Associated Osteonecrosis of the Femoral Head: A 15-Year Multicenter Study},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2025.05.043}
}
EUVIMED